Regulation of cytokine release and anti-tumor effect of anti-CD20 CAR modified expanded natural killer cells by ALT-803, an Il-15 superagonist

被引：0
|
作者：
Chu, Yaya [1 ]
Su, Nang Kham [1 ]
Hamby, Carl [2 ]
Jeng, Emily K. [3 ]
Alter, Sarah [4 ]
Barth, Mathew [5 ]
Wong, Hing C. [3 ]
Lee, Dean A. [6 ]
Cairo, Mitchell S. [1 ,7 ,8 ,9 ,10 ]
机构：
[1] New York Med Coll, Pediat, Valhalla, NY 10595 USA
[2] New York Med Coll, Microbiol & Immunol, Valhalla, NY 10595 USA
[3] HCW Biol, Miramar, FL USA
[4] Altor BioSci, Miramar, FL USA
[5] SUNY Buffalo, Dept Pediat, Buffalo, NY USA
[6] Nationwide Childrens Hosp, Hem Onc BMT, Columbus, OH USA
[7] New York Med Coll, Maria Fareri Childrens Hosp, Med, Valhalla, NY 10595 USA
[8] New York Med Coll, Maria Fareri Childrens Hosp, Pathol, Valhalla, NY 10595 USA
[9] New York Med Coll, Maria Fareri Childrens Hosp, Microbiol & Immunol, Valhalla, NY 10595 USA
[10] New York Med Coll, Maria Fareri Childrens Hosp, Cell Biol & Anat, Valhalla, NY 10595 USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 182卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
89
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [1] REGULATION OF CYTOKINE RELEASE AND ANTI-TUMOR EFFECT OF ANTI-CD20 CAR MODIFIED EXPANDED NATURAL KILLER CELLS BY ALT-803, AN IL-15 SUPERAGONIST
    Chu, Yaya
    Lee, Fangyu
    Hamby, Carl
    Misarti, Jesse
    Hang, Brian
    Ayello, Janet
    Zhang, Melanie
    Zhu, Hongwen
    Wong, Hing
    Lee, Dean
    Cairo, Mitchell
    EXPERIMENTAL HEMATOLOGY, 2016, 44 (09) : S64 - S64
  • [2] Regulation of Cytokine Release and Anti-Burkitt Lymphoma (BL) Effects of Anti-CD20 Car Modified Expanded Natural Killer Cells by ALT-803, AN IL-15 Superagonist
    Chu, Y.
    Lee, F.
    Hamby, C.
    Misarti, J.
    Hang, B.
    Ayello, J.
    Zhang, M.
    Zhu, H.
    Wong, H.
    Lee, D. A.
    Cairo, M.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S19 - S19
  • [3] Regulation of Cytokine Release and Anti-Tumor Effects of Expanded NK and CAR NK by ALT-803, an IL-15 Superagonist
    Chu, Yaya
    Hamby, Carl
    Misarti, Jesse
    Tesoriero, Jack
    Rosenblum, Jeremy
    Wong, Hing C.
    Lee, Dean A.
    Cairo, Mitchell S.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S100 - S101
  • [4] THERAPEUTIC EFFECTS OF ALT-803, AN IL-15 SUPERAGONIST, IN COMBINATION WITH ANTI-CD20 CHIMERIC ANTIGEN RECEPTOR MODIFIED EXPANDED NATURAL KILLER CELLS AGAINST BURKITT LYMPHOMA (BL)
    Chu, Y.
    Lee, F.
    Ayello, J.
    Hang, B.
    Zhang, M.
    Wong, H.
    Lee, D.
    Cairo, M.
    CYTOTHERAPY, 2016, 18 (06) : S59 - S59
  • [5] Therapeutic Effects of ALT-803, an IL-15 Superagonist, in Combination with Anti-CD20 Chimeric Antigen Receptor Modified Expanded Natural Killer Cells Against Burkitt Lymphoma (BL)
    Chu, Yaya
    Lee, Fangyu
    Ayello, Janet
    Hang, Brian
    Zhang, Melanie
    Wong, Hing C.
    Lee, Dean
    Cairo, Mitchell S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S151 - S151
  • [6] Therapeutic Effects of ALT-803, an IL-15 Superagonist, in Combination with Anti-CD20 Chimeric Antigen Receptor Modified Expanded Natural Killer CELLS Against Pediatric Burkitt Lymphoma (BL)
    Chu, Yaya
    Lee, Fangyu
    Ayello, Janet
    Hang, Brian
    Zhang, Melanie
    Wong, Hing C.
    Lee, Dean A.
    Cairo, Mitchell S.
    BLOOD, 2015, 126 (23)
  • [7] Therapeutic effects of ALT-803, an IL-15 superagonist, in combination with anti-CD20 chimeric antigen receptor modified expanded natural killer cells against pediatric Burkitt lymphoma (BL)
    Chu, Yaya
    Lee, Fangyu
    Ayello, Janet
    Wong, Hing C.
    Lee, Dean A.
    Cairo, Mitchell
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 : 36 - 36
  • [8] ENHANCEMENT OF ANTI-TUMOR ACTIVITY OF EXPANDED NATURAL KILLER CELLS AGAINST GD2+ OSTEOSARCOMA (OS) IN COMBINATION WITH ROMIDEPSIN (HDAC INHIBITOR), ALT-803 (IL-15 SUPERAGONIST) AND DINUTUXIMAB
    Chu, Y.
    Tesoriero, J.
    Rosenblum, J.
    Wong, H. C.
    Lee, D.
    Cairo, M. S.
    CYTOTHERAPY, 2017, 19 (05) : S12 - S13
  • [9] Enhancement of Expanded Natural Killer Cells Against Metastatic Osteosarcoma in Combination with Romidepsin (HDAC Inhibitor) or ALT-803 (IL-15 Superagonist)
    Chu, Yaya
    Tesoriero, Jack
    Rosenblum, Jeremy
    Wong, Hing C.
    Lee, Dean
    Cairo, Mitchell S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S248 - S248
  • [10] Enhancement of Anti-Tumor Activities of Daratumumab Using ALT-803, an IL-15 Superagonist, in an Experimental Model and Against Primary Human Lymphoma Cells
    Wong, Hing C.
    Shrestha, Niraj
    Liu, Bai
    Alter, Sarah
    Jeng, Emily K.
    Fehniger, Todd A.
    Rhode, Peter R.
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
12345